Literature DB >> 223908

New approach to the production of concentrated and purified inactivated polio and rabies tissue culture vaccines.

A L van Wezel, G van Steenis, C A Hannik, H Cohen.   

Abstract

The preparation of inactivated polio and rabies vaccine in tissue culture has been developed into a "Unit Process" at our laboratory during recent years. The process comprises trypsinization of animal kidney cells by the perfusion method, cell/virus cultivation in microcarrier culture and concentration and purification of the virus suspension followed by inactivation. Also, the control tests on the virus suspensions and vaccines are performed, to the greatest possible extent, according to the same procedures. In the meantime, both vaccines thus prepared have been tested in man. High antibody titres have been obtained and no adverse reactions have been observed. The results of a field trial with inactivated poliovaccine, administered at different concentrations, will be presented by Dr Salk. Preliminary concepts for further development of the production and control of these inactivated virus vaccines are discussed.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 223908

Source DB:  PubMed          Journal:  Dev Biol Stand        ISSN: 0301-5149


  15 in total

1.  Introduction to animal cell culture technology-past, present and future.

Authors:  O-W Merten
Journal:  Cytotechnology       Date:  2006-08-03       Impact factor: 2.058

2.  Antigen detection in vivo after immunization with different presentation forms of rabies virus antigen, II. Cellular, but not humoral, systemic immune responses against rabies virus immune-stimulating complexes are macrophage dependent.

Authors:  I J Claassen; A D Osterhaus; M Poelen; N Van Rooijen; E Claassen
Journal:  Immunology       Date:  1998-08       Impact factor: 7.397

3.  Genetic and phenotypic properties of vero cell-adapted Japanese encephalitis virus SA14-14-2 vaccine strain variants and a recombinant clone, which demonstrates attenuation and immunogenicity in mice.

Authors:  Gregory D Gromowski; Cai-Yen Firestone; José Bustos-Arriaga; Stephen S Whitehead
Journal:  Am J Trop Med Hyg       Date:  2014-10-13       Impact factor: 2.345

4.  Dose-response effects in immunizations with keyhole limpet haemocyanin and rabies vaccine: shift in some immunodeficiency states.

Authors:  K Korver; E W Boeschoten; R T Krediet; G van Steenis; P T Schellekens
Journal:  Clin Exp Immunol       Date:  1987-11       Impact factor: 4.330

5.  Cell growth optimization in microcarrier culture.

Authors:  B Mered; P Albrecht; H E Hopps
Journal:  In Vitro       Date:  1980-10

6.  High titre Hog Cholera virus production on Cytodex 3 microcarrier cultures.

Authors:  A Caij; A De Smet; N Dubois; F Koenen
Journal:  Arch Virol       Date:  1989       Impact factor: 2.574

7.  Purification of infectious rubella virus by gel filtration on sepharose 2B compared to gradient centrifugation in sucrose, sodium metrizoate and metrizamide.

Authors:  M Trudel; F Marchessault; P Payment
Journal:  J Virol Methods       Date:  1981-02       Impact factor: 2.014

Review 8.  Poliomyelitis in The Netherlands: a review of population immunity and exposure between the epidemics in 1978 and 1992.

Authors:  H C Rümke; P M Oostvogel; G Van Steenis; A M Van Loon
Journal:  Epidemiol Infect       Date:  1995-10       Impact factor: 2.451

9.  Resetting the adaptive immune system after autologous stem cell transplantation: lessons from responses to vaccines.

Authors:  D M C Brinkman; C M Jol-van der Zijde; M M ten Dam; P A W te Boekhorst; R ten Cate; N M Wulffraat; R Q Hintzen; J M Vossen; M J D van Tol
Journal:  J Clin Immunol       Date:  2007-08-10       Impact factor: 8.317

10.  Culture of respiratory syncytial virus infected diploid bovine nasal mucosa cells on cytodex 3 microcarriers.

Authors:  A J Hayle
Journal:  Arch Virol       Date:  1986       Impact factor: 2.574

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.